ContraFect (CFRX) Misses Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ContraFect (CFRX) PT Trimmed to $7 at Maxim Group as Results Awaited
March 15, 2016 10:22 AM EDTMaxim Group analyst Jason Kolbert maintained a Buy rating but trimmed his price target on ContraFect Corp. (NASDAQ: CFRX) to $7.00 (from $8.00) following quarterly results. The company spent $7.5M and ended with $33M in cash, or a year's worth of capital. The next... More
